Croda contributed its expertise to the Cosmetic Ingredient Review (CIR) panel in Washington DC earlier this summer through its Sederma division.
The Cosmetic Ingredient Review (CIR) panel routinely analyses and assesses the safety of individual ingredients that are used in cosmetic products, and has worked for 35 years in partnership with the US Food and Drug Administration (FDA) and the cosmetic industry to make sure the most up-to-date information is captured for cosmetic ingredients. On 15 June 2015, a representative from Sederma delivered expert contributions to a discussion around ingredients produced from plant cell technology that falls under the expertise of IRB by Sederma (Instituto di Ricerche Biotecnologiche SpA), a pioneer in the use of this technology for the cosmetic industry. To assist their review of various cosmetic ingredients derived from Centella asiatica, the panel had requested an expert to provide them with a better understanding of Centella derivatives from plant cell culture, namely callus culture and meristem cell culture, and how those products might differ in composition compared to other plant extracts.
Sederma’s presentation on plant cell culture technology for the cosmetic industry provided the panel with an understanding that allowed them to issue a final ruling, concluding that these products are safe for cosmetic use.
